CENCI, Elio
 Distribuzione geografica
Continente #
NA - Nord America 3.924
EU - Europa 3.320
AS - Asia 1.151
SA - Sud America 39
Continente sconosciuto - Info sul continente non disponibili 7
AF - Africa 6
OC - Oceania 4
Totale 8.451
Nazione #
US - Stati Uniti d'America 3.874
UA - Ucraina 860
IE - Irlanda 680
IT - Italia 616
SE - Svezia 397
HK - Hong Kong 358
VN - Vietnam 278
SG - Singapore 249
DE - Germania 190
FI - Finlandia 182
RU - Federazione Russa 148
CN - Cina 143
GB - Regno Unito 74
FR - Francia 61
TR - Turchia 52
KR - Corea 28
BR - Brasile 26
BE - Belgio 25
CA - Canada 25
MX - Messico 24
CH - Svizzera 21
CZ - Repubblica Ceca 21
IR - Iran 10
UZ - Uzbekistan 10
AT - Austria 9
CL - Cile 7
EU - Europa 7
GR - Grecia 7
PL - Polonia 7
AZ - Azerbaigian 6
LB - Libano 6
NL - Olanda 5
AU - Australia 4
JP - Giappone 4
MK - Macedonia 4
RO - Romania 4
BG - Bulgaria 3
CO - Colombia 3
PH - Filippine 3
SD - Sudan 3
AR - Argentina 2
CI - Costa d'Avorio 2
HU - Ungheria 2
RS - Serbia 2
BN - Brunei Darussalam 1
EE - Estonia 1
EG - Egitto 1
HR - Croazia 1
IN - India 1
MY - Malesia 1
PE - Perù 1
SV - El Salvador 1
TW - Taiwan 1
Totale 8.451
Città #
Chandler 785
Dublin 680
San Mateo 432
Jacksonville 422
Hong Kong 358
Dong Ket 277
Boardman 255
Medford 174
Princeton 171
Singapore 166
Altamura 153
Wilmington 148
Ann Arbor 130
Perugia 129
Lawrence 121
Des Moines 85
Andover 72
Beijing 68
Saint Petersburg 50
Izmir 49
Falls Church 44
Ashburn 42
Milan 33
Norwalk 28
Seoul 28
Rome 27
Helsinki 24
Redwood City 24
Brussels 23
Redmond 21
Woodbridge 20
Los Angeles 16
Ottawa 15
San Paolo di Civitate 15
Brno 13
Munich 13
New York 12
Bologna 11
Florence 11
Ardabil 10
Auburn Hills 10
Santa Clara 9
Toronto 9
Moscow 8
Pisa 8
Dallas 7
Baku 6
Houston 6
Monmouth Junction 6
Nanning 6
Puebla City 6
Shanghai 6
Den Haag 5
Frankfurt Am Main 5
Naples 5
Brescia 4
Busto Arsizio 4
Kiev 4
Leawood 4
Livorno 4
L’Aquila 4
Parma 4
Porto Alegre 4
Quarrata 4
Santiago 4
Tokyo 4
Zhengzhou 4
Albinea 3
Bastia umbra 3
Catania 3
Catanzaro 3
Como 3
Foligno 3
Frascati 3
Guadalupe 3
León 3
Mexico 3
Olomouc 3
Pozzallo 3
San Diego 3
Skopje 3
Timisoara 3
Torreón 3
Udine 3
Abidjan 2
Augusta 2
Bogotá 2
Buenos Aires 2
Buti 2
Council Bluffs 2
Credaro 2
Cuernavaca 2
Davao City 2
Dearborn 2
Fino Mornasco 2
Follonica 2
Hefei 2
Lausanne 2
Melegnano 2
Modugno 2
Totale 5.388
Nome #
Microbiologia Medica, Murray P.R., Rosental K.S., Pfaller M.A., settima edizione Italiana 180
Frazionamento bioguidato e attività antivirale di furanosesquiterpeni da Commiphora erythraea (Ehrenb) Engl. 163
Impiego dell’alga verde chlamydomonas reinhardtii per la produzione di idrogeno 111
Attività immunoadiuvante della Candida albicans in topi singenici e allogenici inoculati con linfoma LSTRA da virus di Moloney. 101
A case of Capnocytophaga canimorsus sepsis and suspected myocardial injury following a dog bite 94
The glucocorticoid-induced tumor necrosis factor receptor-related gene modulates the response to Candida albicans infection 91
Diagnosi molecolare di sepsi: impiego della PCR Real-Time 91
Cytokine- and T helper-dependent immunity in murine aspergillosis. 87
T helper 2 antagonists restore antifungal T helper immunity in mice with T cell-depleted bone marrow transplantation 85
Antibody Constant Region Peptides Can Display Immunomodulatory Activity through Activation of the Dectin-1 Signalling Pathway 81
Comparative antimicrobial activity by alveolar macrophages and peripheral blood monocytes in pulmonary sarcoidosis. 80
Neutralization of IL-10 up-regulates nitric oxide production and protects susceptible mice from challenge with Candida albicans. 80
Aeromonas veronii biovar veronii septicaemia and acute suppurative cholangitis in a patient with hepatitis B 80
Attività terapeutica di un peptide sintetico killer nei confronti di criptococcosi sperimentali. 79
Differenti profili genetici tra isolati ambientali e campioni clinici P. aeruginosa in un reparto di terapia intensiva. 78
Nanoemulsion formulation of a new Candida albicans CYP51 inhibitor 77
Any antibody fragment might exert antifungal activity 76
Antigen-specific cytolysis of infected cells in murine candidiasis. 76
RATIONALE FOR CYTOKINE AND ANTI-CYTOKINE THERAPY OF CANDIDA-ALBICANS INFECTION 76
Confronto tra l'attività immunoadiuvante della Candida albicans e del BCG. In: Atti del XVIII Congresso Nazionale della Società Italiana di Microbiologia. Fiuggi Terme, 2-4 Giugno 1978, vol. II: 1029-1038, 1978. 75
Differenti profili genetici tra isolati ambientali e campioni clinici P. aeruginosa in un reparto di terapia intensiva - 2° Congresso Nazionale SIMPIOS 74
Antibody complementarity-determining regions (CDRs): a bridge between adaptive and innate immunity. 73
Diagnostic performance of a multiple real-time PCR assay in patients with suspected sepsis hospitalized in an internal medicine ward 72
Cell-mediated immunity to chemically xenogenized tumors--IV. Production of lymphokine activity by, and in response to, highly immunogenic cells. 70
Antiviral furanosesquiterpenes from Commiphora erythraea 68
Interleukin 18 restores defective Th1 immunity to Candida albicans in caspase 1-deficient mice. 68
Accelerate Pheno™ system in sepsis by Gram-negative pathogens: four months of hospital experience 68
Comparison of conventional culture with SeptiFast real-time PCR for microbial pathogen detection in clinical specimens other than blood. 67
Procalcitonin levels in gram-positive, gram-negative, and fungal bloodstream infections 67
A multidrug-resistant Pseudomonas aeruginosa isolate from a lethal case of sepsis induces necrosis of human neutrophils 65
Antifungal type I responses are upregulated in IL-10-deficient mice. 65
Acute appendicitis due to Cytomegalovirus in an apparently immunocompetent patient: a case report 65
Cryptococcus neoformans esposto ad Indinavir promuove un'efficiente risposta immune nell'ospite immunocompromesso 63
Rapid identification of bacterial and fungal pathogens from positive blood cultures by MALDI-TOF MS 63
An immunoregulatory role for neutrophils in CD4+ T helper subset selection in mice with candidiasis. 62
A microbial polysaccharide promotes selective elimination of pathogenic T cells from peripheral blood of rheumatoid arthritis patients by apoptosis induction. 62
Accelerate Pheno™ blood culture detection system: a literature review 62
Functional defect of natural immune system in an apparent immunocompetent patient with pulmonary cryptococcosis: Case Report. 61
Mechanisms of cell-mediated immunity in fungal infection. 60
Neutrophils and the adaptive immune response to Candida albicans. 60
A role for Cryptococcus neoformans galactoxylomannan in T cell apoptosis and function. 60
Bulky 1,4-benzoxazine derivatives with antifungal activity 60
Impaired neutrophil response and CD4+ T helper cell 1 development in interleukin 6-deficient mice infected with Candida albicans. 59
Defective co-stimulation and impaired Th1 development in tumor necrosis factor/lymphotoxin-alpha double-deficient mice infected with Candida albicans. 59
Breastfeeding and trasmission of cytomegalovirus to preterm infants. Case report and kinetic of CMV-DNA in breast milk 59
ANTI-CYTOKINE THERAPY OF MURINE CANDIDIASIS 59
Defective antifungal T-helper 1 (TH1) immunity in a murine model of allogeneic T-cell-depleted bone marrow transplantation and its restoration by treatment with TH2 cytokine antagonists. 58
Anti-cytokine therapy of murine candidiasis. 58
Alcune notazioni tecniche sulla esecuzione dei tests per lo studio della immunità verso il tetano. P. Marconi, F. Bistoni, L. Tissi, L. Mosci, E. Cenci, G. Sbaraglia, M. Pitzurra. Ann. Sclavo, 22: 245-247, 1980. 58
Defective candidacidal activity of alveolar macrophages and peripheral blood monocytes from patients with chronic obstructive pulmonary disease. 57
A synthetic peptide as a novel anticryptococcal agent 57
Cryptococcus neoformans capsular polysaccharide component Galactoxylomannan induces apoptosis of human T cells through activation of Caspase-8 57
Diagnosis of infective endocarditis: comparison of the LightCycler SeptiFast (Roche Diagnostics) real-time PCR with blood culture. 57
Treating Primary Arthroprosthesis Infection Caused by Mycobacterium abscessus subsp. abscessus 57
Evaluation of Lumipulse® G SARS-CoV-2 antigen assay automated test for detecting SARS-CoV-2 nucleocapsid protein (NP) in nasopharyngeal swabs for community and population screening 57
Studio sulla resistenza verso l’infezione sistemica indotta da specie diverse di Candida in topi normali ed immunodepressi con ciclofosfamide 56
Immunosuppressive effect of cyclosporin A on resistance to systemic infection with Candida albicans. 55
Innate and adaptive immunity to Candida albicans: a new view of an old paradigm. 55
Candida albicans-specific Ly-2+ lymphocytes with cytolitic activity. 55
T helper cell type 1 (Th1)- and Th2-like responses are present in mice with gastric candidiasis but protective immunity is associated with Th1 development. 55
CD4+ subset expression in murine candidiasis. Th responses correlate directly with genetically determined susceptibility or vaccine-induced resistance. 55
Attività immunoadiuvante e immunochemioterapica della Candida albicans in una leucemia linfoide trapiantabile. P. Marconi, F. Bistoni, G. Sbaraglia, E. Cenci, L. Tissi, M. Pitzurra, E.Bonmassar. Ann. Sclavo, 22: 478, 1980. 55
A commercially available multiplex real-time PCR for detection of pathogens in cardiac valves from patients with infective endocarditis. 55
Diagnostic accuracy of presepsin (sCD14-ST) and procalcitonin for prediction of bacteraemia and bacterial DNAaemia in patients with suspected sepsis. 55
Measurement and prediction of antimicrobial resistance in bloodstream infections by ESKAPE pathogens and Escherichia coli 55
IL12 in Candida albicans infections. 54
T cell subsets and IFN-gamma production in resistance to systemic candidosis in immunized mice. 54
Produzione di idrogeno. Impiego dell'alga verde Chlamydomonas Reinhardtii 53
T-cell subsets, IFN-gamma production and efferent specificity in anti-parental tumor immunity induced by mouse sensitization with xenogenized variant cells. 53
Specific and non-specific immunity to Candida albicans: a lesson from genetically modified animals. 52
[Immunogenic activity of hemocyanin from the hemolymph of Helix pomatia and Octopus vulgaris]. 52
Induction of protective Th1 responses to Candida albicans by antifungal therapy alone or in combination with an interleukin-4 antagonist. 51
Tipranavir exhibits different effects on opportunistic pathogenic fungi. 51
Course of primary candidiasis in T cell-depleted mice infected with attenuated variant cells. 51
Physiopathological role of cytokines induced by Candida. Rational basis for immunoterapy. 51
Gamma interferon modifies CD4+ subset expression in murine candidiasis. 50
Indinavir-treated Cryptococcus neoformans promotes an efficient antifungal immune response in immunosuppressed hosts. 50
Cryptococcus neoformans galactoxylomannan is a potent negative immunomodulator, inspiring new approaches in anti-inflammatory immunotherapy 50
[The use of BCG as immunoadjuvant in combination with antitumor drugs in a virus induced leukemia. II]. 49
Delayed-type hypersensitivity to tumor antigens co-expressed with immunogenic determinants induced by xenogenization. 49
GALACTOXYLOMANNAN IS A POWERFUL IMMUNE SYSTEM MODULATOR ABLE TO REBALANCE TREG/TH17 RATIO IN RHEUMATOID ARTHRITIS 49
TGF-beta is important in determining the in vivo patterns of susceptibility or resistance in mice infected with Candida albicans. 48
Course of primary candidiasis in T cell-depleted mice infected with attenuated variant cells. 48
Tolerance to staphylococcal enterotoxin B initiated Th1 cell differentiation in mice infected with Candida albicans 48
IFN-gamma is required for IL-12 responsiveness in mice with Candida albicans infection. 47
Influence of indinavir on virulence and growth of Cryptococcus neoformans 47
Immunosuppressive effect of cyclosporin A on resistance to systemic infection with Candida albicans 47
Elucidating the immunological function of the Cryptococcus neoformans capsule 47
Low-dose streptozotocin-induced diabetes in mice. II. Susceptibility to Candida albicans infection correlates with the induction of a biased Th2-like antifungal response. 46
Sviluppo di un dispositivo per l’ottenimento di Idrogeno mediante processi Fotobiologici 46
Type 1 and type 2 cytokines: from basic science to fungal infections. 46
[Use of BCG as an immunoadjuvant in combination with antitumor agents in virus-induced leukemia]. 46
[Technic for studying antitetanus immunity]. 46
[Further study of immunopotentiation in experimental antiblastic therapy by inactivated yeasts and glucan]. 46
Low-dose streptozotocin-induced diabetes in mice. I. Course of Candida albicans infection. 45
IL-10 is required for development of protective Th1 responses in IL-12-deficient mice upon Candida albicans infection. 45
CD80+Gr-1+ myeloid cells inhibit development of antifungal Th1 immunity in mice with candidiasis. 45
Natural killer cells do not play a dominant role in CD4+ subset differentiation in Candida albicans-infected mice. 44
Evaluation of IVD 3.0 Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of Mycobacterium tuberculosis and nontuberculous mycobacteria and its use in routine diagnostics. 44
Cure of murine candidiasis by recombinant soluble interleukin-4 receptor. 44
Totale 6.293
Categoria #
all - tutte 35.512
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.512


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020751 0 0 120 6 107 7 139 18 158 96 13 87
2020/20211.584 8 132 33 125 447 59 124 11 167 43 135 300
2021/20221.529 56 295 52 73 97 31 14 426 33 47 173 232
2022/20232.581 198 441 36 197 200 329 9 108 904 21 98 40
2023/20241.069 79 121 55 27 13 9 285 21 133 29 137 160
2024/2025344 37 235 72 0 0 0 0 0 0 0 0 0
Totale 8.785